Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures

NAEnrolling by invitationINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 18, 2021

Primary Completion Date

June 30, 2025

Study Completion Date

January 31, 2026

Conditions
Cervical StenosisSpondylolisthesisCervical RadiculopathyCervical Disc Disorder
Interventions
OTHER

AlloWrap® Amniotic Membrane

AlloWrap is a human amniotic membrane designed to provide a biologic barrier following surgical repair.

Trial Locations (1)

92120

Spine Institute of San Diego, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AlloSource

INDUSTRY

NCT04684901 - Effectiveness of AlloWrap® for the Reduction of Inflammation in ACDF Procedures | Biotech Hunter | Biotech Hunter